ADMS
Adamas Pharmaceuticals Inc
Sign up for free!
Get instant access to stock market data and news with our free APIs.
Latest news data for ADMS
Supernus Pharmaceuticals: Shares Could Get Cheaper (NASDAQ:SUPN)
seekingalpha.com
Global Alzheimers Disease Diagnostics and Therapeutics Market Size to grow USD 21704.4 Million by 2030 | CAGR of 5.5%
globenewswire.com
Parkinson’s Disease Market Size Will Achieve USD 6,705 Million by 2030 growing at 11.5% CAGR - Exclusive Report by Acumen Research and Consulting
globenewswire.com
Global Alzheimer's Therapeutics Market Report 2022-2030 - Incidence and Cost Burden of Dementia Associated with AD is Expected to Boost Market Growth
prnewswire.com
8 Stocks to Buy According to Devesh Gandhi’s SilverArc Capital
insidermonkey.com
Parkinson's Disease (PD) Drugs market - 37% of Growth to Originate from Europe | Evolving Opportunities with AbbVie Inc. & Amneal Pharmaceuticals Inc. | Technavio
prnewswire.com
With 6.3% CAGR, Multiple Sclerosis Drugs Market Size Worth USD 41.99 Billion in 2028
globenewswire.com
Supernus Reports Final Audited Fourth Quarter and Full Year 2021 Financial Results
globenewswire.com
Acer Therapeutics : Reports Q4 and Full Year 2021 Financial Results and Provides Corporate Update - Form 8-K
marketscreener.com
Acer Therapeutics Reports Q4 and Full Year 2021 Financial Results and Provides Corporate Update
globenewswire.com